RxDoctor Payments Data

Brandon Scott, DO

Gastroenterology · Pocatello, IDNPI 1972980548

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 54.6% of the total. That places this record below the midpoint for gastroenterology clinicians in ID, where the typical reported total is $1,538.

$959in general payments, 2019–2025

Across 40 payments — averaging $23.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$523
  • Medtronic$53
  • Boston Scientific$50
  • Gilead$47
  • Pentax Of America, Inc.$44
  • Ipsen Biopharmaceuticals, Inc$44
  • plus $197 from 8 others

What the payments were for

  • Food & beverage$959100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$959 in reported general payments places this provider in the 40th percentile of 70 gastroenterology providers in Idaho.

See all gastroenterology providers in Idaho

Medicare billing

Part B allowed, 2024
$63,387
Medicare patients
275
Services billed
479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mesalamine13$7,021
Sucralfate23$2,650
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates27$1,829
Omeprazole152$1,790
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl100$1,729
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl123$1,664
Pantoprazole Sodium63$939
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl75$822
Esomeprazole Magnesium17$595
Dicyclomine Hcl13$285
Famotidine20$98
Hydrocortisone11$29

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Pocatello

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →